Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
Dai Nippon Printing Co Ltd
F:DNP0
|
JP |
|
Anhui Conch Cement Co Ltd
SSE:600585
|
CN |
|
Amorepacific Group
KRX:002790
|
KR |
|
Cipher Mining Inc
NASDAQ:CIFR
|
US |
|
Ares Capital Corp
NASDAQ:ARCC
|
US |
|
Hawaiian Electric Industries Inc
NYSE:HE
|
US |
|
Harley-Davidson Inc
NYSE:HOG
|
US |
|
ONEOK Inc
NYSE:OKE
|
US |
|
Tesmec SpA
MIL:TES
|
IT |
|
Payright Ltd
ASX:PYR
|
AU |
|
P
|
Public Storage
SWB:PUP
|
US |
|
Spark New Zealand Ltd
NZX:SPK
|
NZ |
|
Canadian Solar Inc
NASDAQ:CSIQ
|
CA |
|
Black Iron Inc
TSX:BKI
|
CA |
|
Yangzijiang Shipbuilding Holdings Ltd
OTC:YSHLF
|
CN |
|
Nextedia SA
PAR:ALNXT
|
FR |
|
International Consolidated Airlines Group SA
LSE:IAG
|
UK |
|
Coface SA
PAR:COFA
|
FR |
|
A
|
Atos SE
DUS:AXI
|
FR |
|
Renaissancere Holdings Ltd
NYSE:RNR
|
BM |
|
Japan Tobacco Inc
F:JAT
|
JP |
|
Lundin Gold Inc
TSX:LUG
|
CA |
|
T
|
Twist Bioscience Corp
F:0ME
|
US |
Bankruptcy Probability
Biomarin Pharmaceutical Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biomarin Pharmaceutical Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
10.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
150.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biomarin Pharmaceutical Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biomarin Pharmaceutical Inc has total debt of 1.4B USD. This includes both short-term (0 USD) and long-term (1.4B USD) debt.
You can find a full breakdown on its Balance Sheet.
